US Department of Health and Human
Services, Office of the Surgeon General. The surgeon general’s call to action to prevent deep vein
thrombosis and pulmonary embolism.
http://www.surgeongeneral.gov/topics/deepvein/.RetrievedNovember17,
2009.
2.
Heit
JA, Cohen
AT, Anderson
FAEstimated annual number of incident and recurrent, non-fatal
and fatal venous thromboembolism (VTE) events in the US [ASH annual meeting abstract 910].
Blood. 2005;106.
3.
Geerts
WH, Pineo
GF, Heit
JA, et al. Prevention of venous thromboembolism: the Seventh
ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3
suppl):338S-400S.
4.
The Coalition to Prevent Deep-Vein
Thrombosis. About DVThttp://www.preventdvt.org/aboutDvt/symptoms.aspx. .
Retrieved November 17, 2009.
5.
Gerotziafas GT , Samama MMProphylaxis of venous
thromboembolismin medical patients. Curr Opin Pulm Med.
2004 ;10:356-365.
6.
The Joint Commission. Performance measure
initiatives: national consensus standards for prevention and care of venous thromboembolism
(VTE)-last updated 4/2009.
http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/VTE.htm.
Retrieved November 17, 2009.
7.
Anderson FA Jr , Zayaruzny M., Heit JA, Fidan D., Cohen ATEstimated annual numbers of US
acute-care hospital patients at risk for venous thromboembolism . Am J
Hematol.
2007;82:777-782.
8.
Hirsch DR, Ingenito EP, Goldhaber SZPrevalence of deep venous
thromboembolism among patients in medical intensive care. JAMA.
1995;274:335-337.
9.
Stein PD, Beemath A., Olson RETrends in the incidence of
pulmonary embolism and deep venous thromboembolism in hospitalized patients.
Am J Cardiol. 2005
;95:1525-1526.
10.
Kahn SR, Ginsberg JSRelationship between deep
venous thromboembolism and post-thrombotic syndrome . Arch Intern
Med.
2004;164:17-26.
11.
Pengo V., Lensing AW, Prins MH, et al. Incidence of chronic
thromboembolitic pulmonary hypertension after pulmonary embolism. N Engl J
Med. 2004
;350:2257-2264.
12.
Cohen AT, Tapson V., Bergmann JF, et al. Venous thromboembolism
risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational staged
cross-sectional study . Lancet.
2008;371:387-394.
13.
Tapson VF, Decousus H., Pini M., et al. Venous thromboembolism
prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical
Prevention Registry on Venous Thromboembolism. Chest.
2007;132: 936-945.
14.
Goldhaber SZFor the DVT FREE Steering
Committee: a prospective registry of 5451 patients with confirmed deep vein
thrombosis. Am J Cardiol.
2004;93:259-262.
15.
Kakkar AK, Levine M., Pinedo HM, Wolff R., Wong J.Venous thrombosis in cancer
patients: insights from the FRONTLINE survey. Oncologist.
2003;8:381-388.
16.
National Quality Forum .NQF-endorsed
standards.
http://www.qualityforum.org/Measures_list.aspx?keyword=serious+reportable+events&from=header
. Retrieved November 17, 2009.
17.
Dentali F., Douketis JD, Gianni M., Lim W., Crowther M.Meta-analysis: anticoagulant
prophylaxis to prevent symptomatic venous thromboembolism in hospital medical
patients. Ann Intern Med .
2007;146:278-288.
18.
Tapson VF, Hyers TM, Waldo AL, et al. Antithrombotic therapy
practices in US hospitals in an era of practice guidelines. Arch Intern
Med. 2005
;65:1458-1464.
19.
Kucher N., Koo S., Quiroz R., et al. Electronic alerts to
prevent venous thromboembolism among hospitalized patients. N Engl J
Med.
2005;352:969-977.
20.
Tooher R., Middleton P., Pham C., et al. A systematic review of
strategies to improve prophylaxis for venous thromboembolism in hospitals.
Ann Surg.
2005;241:397-415.
